Back to Search
Start Over
Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2019 Jun; Vol. 60 (6), pp. 1563-1567. Date of Electronic Publication: 2019 Jan 09. - Publication Year :
- 2019
- Subjects :
- Drug Resistance, Neoplasm
Female
France epidemiology
Humans
Kaplan-Meier Estimate
Leukemia, Lymphocytic, Chronic, B-Cell epidemiology
Leukemia, Lymphocytic, Chronic, B-Cell mortality
Male
Multicenter Studies as Topic
Recurrence
Retreatment
Treatment Outcome
Antineoplastic Agents, Immunological therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell pathology
Rituximab therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 60
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 30624147
- Full Text :
- https://doi.org/10.1080/10428194.2018.1533130